MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves

MDMA (3,4-methylenedioxymethamphetamine) or ‘ecstasy’ is a ring-substituted amphetamine derivative, which is widely used as a recreational drug, most particularly at dances and raves. Around 80–95% of dancers/ravers report using ecstasy/MDMA, compared to 5–15% of young people in general. This paper will consider the possible contribution of stimulatory environmental conditions to the neuropsychobiological effects of MDMA. Animal research shows that heat and crowding potentiate the acute effects of MDMA. Social interaction and intravenous drug self-administration in laboratory rats are significantly enhanced when MDMA is given under hot ambient temperatures. Loud noise and physical activity can also contribute to the general overarousal. Furthermore, MDMA impairs homeostatic thermal control in rats, leading them to overheat in hot environments. The human implications of these findings are that the hot, noisy and overcrowded conditions at raves may be providing the ideal environment to heighten the acute drug response. In recreational users, the acute medical dangers of MDMA comprise a constellation of hyperthermia-related abreactions, which generally only occur when it has been taken in hot and crowded environments. MDMA is well established as a serotonergic neurotoxin in laboratory animals, but heat and overcrowding increase the degree of distal axon terminal loss. If this also occurs in humans, then the stimulatory environments of clubs and raves may heighten the likelihood of adverse neuropsychological sequelae in recreational ecstasy users. Consistent with this prediction, the extent of self-reported dancing/exercise when on MDMA has recently been shown to be associated with significantly more psychobiological problems afterwards.

[1]  H. Dingle,et al.  Patterns of recreational drug use at dance events in Edinburgh, Scotland. , 2001, Addiction.

[2]  R. Dafters Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing , 1995, Physiology & Behavior.

[3]  M. Bourin,et al.  3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans , 1999, Neuroscience & Biobehavioral Reviews.

[4]  J A Gunn,et al.  The action of some amines related to adrenaline. Cyclohexylalkylamines , 1940, The Journal of physiology.

[5]  A. Blokland,et al.  Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes , 2003, Psychopharmacology.

[6]  J. O'Callaghan,et al.  Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat , 1991, Pharmacology Biochemistry and Behavior.

[7]  T. Ernst,et al.  Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users , 1999, Journal of magnetic resonance imaging : JMRI.

[8]  A. Parrott,et al.  Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity , 2002, Pharmacology Biochemistry and Behavior.

[9]  P. Tossmann,et al.  The Use of Drugs within the Techno Party Scene in European Metropolitan Cities , 2001, European Addiction Research.

[10]  A. Parrott,et al.  Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug , 2001, Journal of psychopharmacology.

[11]  G. D. den Heeten,et al.  Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results. , 2002, AJNR. American journal of neuroradiology.

[12]  U. McCann,et al.  (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals , 2000, Neuropsychobiology.

[13]  V. Sánchez,et al.  Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge’ ingestion) low dose of MDMA , 2004, Psychopharmacology.

[14]  M. Spitzer,et al.  Psychological Effects of MDE in Normal Subjects , 1993, Neuropsychopharmacology.

[15]  A. Morton,et al.  Methamphetamine toxicity in mice is potentiated by exposure to loud music , 2001, Neuroreport.

[16]  A. Scholey,et al.  Understanding Drugs and Behaviour , 2004 .

[17]  N. Solowij,et al.  Ecstasy use in Australia: patterns of use and associated harm. , 1999, Drug and alcohol dependence.

[18]  Z. Szabo,et al.  Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.

[19]  T. Buchanan,et al.  Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users , 2002, Human psychopharmacology.

[20]  D E Nichols,et al.  An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. , 1998, Neurotoxicology.

[21]  I. McGregor,et al.  Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. , 2003, European journal of pharmacology.

[22]  B. Sahakian,et al.  Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users , 2002, Psychopharmacology.

[23]  A. Winstock,et al.  Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. , 2001, Drug and alcohol dependence.

[24]  A. Parrott,et al.  Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. , 2000, Drug and alcohol dependence.

[25]  W. van den Brink,et al.  Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach , 2001, Human psychopharmacology.

[26]  E. Rüther,et al.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its congeners , 2005, Journal of Neural Transmission.

[27]  F. Schifano Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies , 2000, Neuropsychobiology.

[28]  J. Strang,et al.  Understanding reasons for drug use amongst young people: a functional perspective. , 2001, Health education research.

[29]  M. Morgan,et al.  Ecstasy (MDMA): a review of its possible persistent psychological effects , 2000, Psychopharmacology.

[30]  A. B. Scholey,et al.  Differential effects of Ecstasy and cannabis on self‐reports of memory ability: a web‐based study , 2001, Human psychopharmacology.

[31]  S. Dawling,et al.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") , 1992, The Lancet.

[32]  A. Parrott Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change , 2000, Neuropsychobiology.

[33]  Andrew C. Parrott,et al.  Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects , 1997 .

[34]  M. Colado,et al.  The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) , 2003, Pharmacological Reviews.

[35]  M. Colado,et al.  A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation , 2001, Psychopharmacology.

[36]  J. V. van Gerven,et al.  Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.

[37]  H. Pope,et al.  Drug use and life style among college undergraduates: a 30-year longitudinal study. , 2001, The American journal of psychiatry.

[38]  G. Goodwin,et al.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) , 1995, Psychopharmacology.

[39]  N. Solowij,et al.  Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects , 2004, Journal of psychopharmacology.

[40]  L. Seiden,et al.  Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat , 1998, The Journal of Neuroscience.

[41]  L. Seiden,et al.  Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. , 1985, Science.

[42]  L. Baute,et al.  Emergency medical assistance during a mass gathering. , 1999, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[43]  A. Parrott Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research , 2001, Human psychopharmacology.

[44]  P. Skudlarski,et al.  Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: possible relationship to neurotoxic effects , 2004, Psychopharmacology.

[45]  T. Ullrich,et al.  Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice , 2003, Psychopharmacology.

[46]  B. Stimmel,et al.  The Love Drug: Marching to the Beat of Ecstasy , 1998 .

[47]  B. Maycock,et al.  ‘Weddings, parties, anything…’, a qualitative analysis of ecstasy use in Perth, Western Australia , 2001 .

[48]  A. Scholey,et al.  Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A Web-Based Study , 2003, Journal of psychopharmacology.

[49]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[50]  F. Vollenweider,et al.  Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies , 2001, Human psychopharmacology.

[51]  R. Dafters,et al.  Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not by fenfluramine , 1998, Psychopharmacology.

[52]  M. Colado,et al.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function , 2004, Psychopharmacology.

[53]  M. Thiébot,et al.  Behavioral Effects of Cannabinoid Agents in Animals. , 1999, Critical reviews in neurobiology.

[54]  U. McCann,et al.  (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies , 2000, Neuropsychobiology.